SK3 Group Inc 的盈利质量评分为 B+/46.568367。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
SK3 Group Inc 何时发布财报?
SK3 Group Inc 的下一份财报预计在 发布
SK3 Group Inc 的预期收益是多少?
根据华尔街分析师的预测,SK3 Group Inc 的预期收益为 $
SK3 Group Inc 是否超出收益预期?
SK3 Group Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0
开盘价
$0
当日区间
$0 - $0
52周范围
$0 - $0.0005
交易量
27.5K
平均成交量
198.8K
股息收益率
--
每股收益(TTM)
0.03
市值
$8.6K
什么是 SKTO?
SK3 Group, Inc. offers services in the healthcare industry. The company is headquartered in Harrison, New York. The company went IPO on 2007-05-31. The Company’s subsidiary Medical Greens provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens contracted with 15 collectives to provide these services through marketing, management, licensing and service agreements. The firm has focused on acquisitions of related companies with cash flowing operations and, in that regard, the Company signed a definitive agreement to acquire Paragon Consulting Group (PCG). Products licensed by SK3 Group include: YAK, Canna-Loz, Yeti and Dharmanol.